[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

NCT05619016 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms
Gastric Neoplasms Malignant
Breast Cancer
HER2-positive Gastric Cancer

Interventions

DIAGNOSTIC_TEST: [68Ga]Ga-ABY-025 PET
DIAGNOSTIC_TEST: Biopsy and analysis of HER2 expression

Sponsor

Karolinska University Hospital